Abnormal extracellular matrix in Ehlers‐Danlos syndrome type IV due to the substitution of glycine 934 by glutamic acid in the triple helical domain of type III collagen
Authors:
- 1 December 1996
- journal article
- case report
- Published by Wiley in Clinical Genetics
- Vol. 50 (6) , 442-445
Abstract
A unique substitution of glycine 934 by glutamic acid in the triple helical domain of type III collagen was identified in a proband with Ehlers-Danlos syndrome type IV. The substitution was due to the transition of G 3302 to A in alpha 1(III) cDNA which is encoded by exon 46 of COL3A1. It resulted in a severe deficiency of type III collagen in fibroblast cultures and dermis. Dilatation of the endoplasmic reticulum of the dermal fibroblasts was probably due to the failure of these cells to secrete type III collagen molecules containing one or more mutant alpha 1(III) chains. The dermal collagen fibrils were narrow, but their constituent type III collagen molecules contained predominantly normal alpha 1(III) chains. As a results, the major effect of the substitution of glycine 934 by glutamic acid was to severely reduce the amount of normal type III collagen available for the formation of heterotypic collagen fibrils in the extracellular matrix.Keywords
This publication has 11 references indexed in Scilit:
- Ehlers-Danlos Syndrome Type IV: A Single Base Substitution of the Last Nucleotide of Exon 34 in COL3A1 Leads to Exon SkippingJournal of Investigative Dermatology, 1995
- Pathomorphological and biochemical alterations in Ehlers-Danlos-Syndrome Type IVPathology - Research and Practice, 1994
- Substitution of glutamic acid for glycine 589 in the triple-helical domain of type III procollagen (COL3A1) in a family with variable phenotype of the Ehlers–Danlos syndrome type IVHuman Molecular Genetics, 1994
- Single base mutation that substitutes glutamic acid for glycine 1021 in the COL3A1 gene and causes Ehlers–Danlos syndrome type IVAmerican Journal of Medical Genetics, 1993
- A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutationHuman Genetics, 1992
- A COL3A1 glycine 1006 to glutamic acid substitution in a patient with ehlers‐danlos syndrome type IV detected by denaturing gradient gel electrophoresisJournal of Inherited Metabolic Disease, 1992
- A mutation in the gene for type III procollagen (COL3A1) in a family with aortic aneurysms.Journal of Clinical Investigation, 1990
- Type I and Type III Collagen Interactions during FibrillogenesisaAnnals of the New York Academy of Sciences, 1990
- Structure of cDNA clones coding for the entire preproα1 (III) chain of human type III procollagen. Differences in protein structure from type I procollagen and conservation of codon preferencesBiochemical Journal, 1989
- Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen.Journal of Biological Chemistry, 1987